Feb 28

New molecular entities approved by FDA

1. Intelence – Tibotec

2. Pristiq – Wyeth

3. Treanda – Cephalon

4. Lexiscan – CV Therapeutics

5. Relistor – Progenics

6. Entereg – Adolor

7. Durezol – Sirion

8. Eovist injection – Bayer

9. Cleviprex – Medicines Company

10. Xenazine – Prestwick
[…continue reading below…]



11. Adre View – GE Healthcare

12. Rapaflo – Silodosin

13. Vimpat tablets – Schwarz Biosciences

14. Toviaz – Pfizer

15. Banzel oral tabs – EISAI

16. Promacta – Glaxosmithkline

17. Tapentadol – Ortho McNeil Janssen

New biologics approved by FDA

18. Arcalyst – Regeneron

19. Cimzia – UCB

20. NPlate – Amgen

for more information, visit http://www.clinical-trials-info.com/.

Tagged with:
preload preload preload